AzTrials
AzTrials

Forward Head PostureFHPNCT07086872

Impact of Adding Integrated Neuromuscular Inhibition Technique to Mulligan Therapy in Symptomatic Forward Head Posture

A study testing Integrated Neuromuscular Inhibition Technique and mulligan therapy, Integrated Neuromuscular Inhibition Technique and mulligan therapy in people with Forward Head Posture, run by Cairo University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

this study will be conducted to investigate the impact of adding integrated neuromuscular inhibition technique to mulligan therapy in symptomatic forward head posture. Read more about this study

Who is it for?
Ages 18 to 35 years
Conditions the study is for
Forward Head Posture
What is being tested?
Integrated Neuromuscular Inhibition Technique and mulligan therapy, Integrated Neuromuscular Inhibition Technique and mulligan therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
No sites listed yet
Study dates
30 Jul 2025to 20 Feb 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • CVA equal or less than 50
  • Had cervical pain for more than three months and had visited an orthopedist clinic

Who cannot join

  • cervical spine spondylosis
  • fractures or cervical spinal surgery
  • Cervical or shoulder neurological movement disorder.
  • Temporo-mandibular surgery, (5) Pathologic trauma

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

alshaymaa abd elazeim, phd contact

01033771553

alshaymaa.shaaban@pt.cu.edu.eg

About this study

this study will be conducted to investigate the impact of adding integrated neuromuscular inhibition technique to mulligan therapy in symptomatic forward head posture.

Read the detailed description

Forward head posture is anterior positioning of the cervical spine, which is regarded as a "bad" head posture and is commonly found in patients who experience problems with the head and neck. Particularly, forward head posture is frequently found in people sitting in front of a computer for prolonged periods. Load increases in the muscles and joints of the cervical spine as a result of forward head posture are considered a major cause of musculoskeletal disorders. INIT is effective as it causes sustained or intermittent compression which causes ischemia reduces local circulation until pressure is released, after which a flushing of fresh oxygenated blood occurs. Mechanoreceptors impulses interface with slower pain messages reducing amount of pain messges reaching the brain, releasing pain relieving hormones, decreasing myofascial pain. Stretches the taut bands of muscles fibers. INIT along with strengthening excercises proved to be beneficial in decreasing disability improving Range of motion. The concept of SNAG is to increase the treatment effects by having patients perform active movements while removing pain in the lesions by means of manipulative therapy. This is a new concept in the manipulative therapy field, and differs from traditional manipulative therapy by combining the active movements of the patients with additional passive movements performed with the aid of therapists

Being tested
Integrated Neuromuscular Inhibition Technique and mulligan therapy, Integrated Neuromuscular Inhibition Technique, mulligan therapy, postural correction exercises
Keywords
Integrated Neuromuscular Inhibition Technique, Mulligan Therapy, Forward Head Posture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Integrated Neuromuscular Inhibition Technique and mulligan therapyOther

    patients will receive Integrated Neuromuscular Inhibition Technique in the form of intermittent ischemic compression, strain counter strain and muscle energy technique and mulligan therapy for limited cervical range of motion

  • Integrated Neuromuscular Inhibition TechniqueOther

    patients will receive Integrated Neuromuscular Inhibition Technique in the form of intermittent ischemic compression, strain counter strain and muscle energy technique

  • mulligan therapyOther

    patients will receive mulligan therapy for limited cervical range of motion

  • postural correction exercisesOther

    the patients will receive two strengthening exercises (deep cervical flexors and scapular retractors) and two stretching: cervical extensors (sub-occipital muscles) and pectoral muscles). The program was based on a program by Harman and Kendall

Study groups in NCT07086872
Study groupRoleWhat they receive
Integrated Neuromuscular Inhibition Technique and mulligan therapyExperimentalthirty patients will receive Integrated Neuromuscular Inhibition Technique and mulligan therapy three times a weeks for six weeks+postural correction exercises
Receives: Other: Integrated Neuromuscular Inhibition Technique and mulligan therapy; Other: postural correction exercises
Integrated Neuromuscular Inhibition TechniqueExperimentalthirty patients will receive Integrated Neuromuscular Inhibition Technique+postural correction exercises three times a weeks for six weeks
Receives: Other: Integrated Neuromuscular Inhibition Technique; Other: postural correction exercises
mulligan therapyExperimentalthirty patients will receive mulligan Technique+postural correction exercises three times a weeks for six weeks
Receives: Other: mulligan therapy; Other: postural correction exercises
postural correction exercisesActive comparatorthirty patients will receive postural correction exercises three times a weeks for six weeks
Receives: Other: postural correction exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain intensity

    visual analogue scale will be used to asses pain intensity which patient will be instructed to put point on line from no pain to tolerable pain. The scale consists of a line, usually 100 mm long, ranging from no pain or discomfort (zero) , to the worst pain that could possibly feel

    Measured: up to six weeks

Secondary outcomes (4)
  1. neck disability

    will be measured by Arabic neck disability index. It contains ten category/classes. Each category contains six choices (zero-five).Score from zero to four no disability, from five to 15 this is mild, From 15 to 24 this is moderate, from 25 to 34 this is severe, more than 34 this is a complete disability

    Measured: up to 6 weeks

  2. pressure pain threshold

    pressure pain threshold pressure pain threshold will be assessed by commander algometer

    Measured: up to six weeks

  3. cervical range of motion

    range of motion will be measured by inclinometer CROM. The CROM (deluxe version - Performance Attainment Associates, Roseville, MN, USA) measures the cervical range of motion5- for fexion, extension, lateral fexion, and rotation using separate inclinometers. These inclinometers are attached to a frame similar to that for eyeglasses one in the sagittal plane for fexion - extension, second in the frontal plane for lateral fexion and a third in the horizontal plane for rotation.

    Measured: up to six weeks

  4. craniovertebral angle

    The craniovertebral angle is identified as the intersection of a horizontal line passing through the C7 spinous process and a line joining the midpoint of the tragus of the ear to the skin overlying the C7 spinous process. it measured by photogrametric methods. when the angle less than or equal 50 degree

    Measured: up to six weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2025
  2. Study start30 Jul 2025 (estimated)
  3. Primary completion20 Feb 2026 (estimated)
  4. Study completion20 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
integrated neuromuscular inhibition and mulligan
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07086872
Sponsor's protocol ID
P.T.REC/012/005806
Acronym
FHP
Status last verified
Jul 2025
First submitted
18 Jul 2025
Last updated
25 Jul 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Integrated Neuromuscular Inhibition Technique and mulligan therapy, Integrated Neuromuscular Inhibition Technique and mulligan therapy in people with Forward Head Posture, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 25 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact alshaymaa abd elazeim, phd (01033771553, alshaymaa.shaaban@pt.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain intensity (time frame: up to six weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in